Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.160
-0.040 (-3.33%)
Jan 2, 2026, 4:00 PM EST - Market closed
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $9.1 million as of January 5, 2026. Its market cap has decreased by -34.75% in one year.
Market Cap
9.10M
Enterprise Value
6.61M
1-Year Change
-34.75%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.28M to $9.10M, a decrease of -95.38%. That is a compound annual growth rate of -47.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 9.10M | -3.33% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.17% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | 197.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |